DEFINITIVE PROXY STATEMENT

Company

Unicycive Therapeutics, Inc.

Filed

April 30, 2025

Period of Report

June 9, 2025

Accession Number

0001213900-25-037613

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →